Cargando…
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
The current standard of care for resected early-stage triple negative breast cancer (TNBC) patients who did not receive systemic preoperative therapy is adjuvant anthracycline- and taxane-based chemotherapy (CT). A network meta-analysis (NMA) of randomized controlled trials (phase III) enrolling pat...
Autores principales: | Petrelli, Fausto, Bertaglia, Valentina, Parati, Maria Chiara, Borgonovo, Karen, De Silva, Pushpamali, Luciani, Andrea, Novello, Silvia, Scartozzi, Mario, Emens, Leisha A., Solinas, Cinzia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792383/ https://www.ncbi.nlm.nih.gov/pubmed/36549170 http://dx.doi.org/10.1016/j.breast.2022.12.004 |
Ejemplares similares
-
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection
por: Parati, Maria Chiara, et al.
Publicado: (2022) -
COVID-19 and Lung Cancer Survival: An Updated Systematic Review and Meta-Analysis
por: Oldani, Simone, et al.
Publicado: (2022) -
Risk of Infection with Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021) -
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
por: Wang, Hanwen, et al.
Publicado: (2021) -
The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023)